← 產業報告目錄
Integrase Inhibitors Market Size, Share & Trends Analysis Report By Drug Class (First-Generation Integrase Inhibitors, Second-Generation Integrase Inhibitors, Others), By Indication (HIV Infection, Other Indications), By Distribution Channel, By End User, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-30頁數 180報告編號 INSIGHTACE-0a8b9c0ce2
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 15.8 Bn, the global Integrase Inhibitors Market is expected to surge to USD 27.9 Bn by 2034, demonstrating a CAGR of 6.0% during the 2025–2034 forecast window.
The Integrase Inhibitors sector involves a type of antiretroviral medications that work by inhibiting the viral enzyme integrase, which is responsible for mixing the viral genome into the dna of the host cell. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is bolstered by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Integrase Inhibitors Market Snapshot
Chapter 4. Global Integrase Inhibitors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Drug Class Estimates & Trend Analysis
5.1. By Drug Class, & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Drug Class:
5.2.1. First-Generation Integrase Inhibitors
5.2.2. Second-Generation Integrase Inhibitors
5.2.3. Others
Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. By Indication & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Indication:
6.2.1. HIV Infection
6.2.2. Other Indications
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By End User:
7.2.1. Hospitals and Clinics
7.2.2. Research Institutes
7.2.3. Others
Chapter 8. Market Segmentation 4: By Distribution Channel Estimates & Trend Analysis
8.1. By Distribution Channel & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Distribution Channel:
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
Chapter 9. Integrase Inhibitors Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Integrase Inhibitors Market revenue (US$ Million) estimates and forecasts By Drug Class, 2021-2034
9.1.2. North America Integrase Inhibitors Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
9.1.3. North America Integrase Inhibitors Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.1.4. North America Integrase Inhibitors Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
9.1.5. North America Integrase Inhibitors Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Integrase Inhibitors Market revenue (US$ Million) By Drug Class, 2021-2034
9.2.2. Europe Integrase Inhibitors Market revenue (US$ Million) By Indication, 2021-2034
9.2.3. Europe Integrase Inhibitors Market revenue (US$ Million) By End User, 2021-2034
9.2.4. Europe Integrase Inhibitors Market revenue (US$ Million) By Distribution Channel, 2021-2034
9.2.5. Europe Integrase Inhibitors Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Integrase Inhibitors Market revenue (US$ Million) By Drug Class, 2021-2034
9.3.2. Asia Pacific Integrase Inhibitors Market revenue (US$ Million) By Indication, 2021-2034
9.3.3. Asia Pacific Integrase Inhibitors Market revenue (US$ Million) By End User, 2021-2034
9.3.4. Asia Pacific Integrase Inhibitors Market revenue (US$ Million) By Distribution Channel, 2021-2034
9.3.5. Asia Pacific Integrase Inhibitors Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Integrase Inhibitors Market revenue (US$ Million) By Drug Class, (US$ Million) 2021-2034
9.4.2. Latin America Integrase Inhibitors Market revenue (US$ Million) By Indication, (US$ Million) 2021-2034
9.4.3. Latin America Integrase Inhibitors Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
9.4.4. Latin America Integrase Inhibitors Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
9.4.5. Latin America Integrase Inhibitors Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Integrase Inhibitors Market revenue (US$ Million) By Drug Class, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Integrase Inhibitors Market revenue (US$ Million) By Indication, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Integrase Inhibitors Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
9.5.4. Middle East & Africa Integrase Inhibitors Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
9.5.5. Middle East & Africa Integrase Inhibitors Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Gilead Sciences
10.2.2. ViiV Healthcare
10.2.3. Merck & Co., Inc.
10.2.4. GlaxoSmithKline PLC
10.2.5. Bristol-Myers Squibb Company
10.2.6. Johnson & Johnson
10.2.7. AbbVie Inc.
10.2.8. Janssen
10.2.9. Pharmaceuticals, Inc.
10.2.10. Theratechnologies Inc.
10.2.11. Shionogi & Co., Ltd.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們